StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Eli Lilly (LLY) PT Lowered to $92 at Jefferies; Reiterates Buy
April 26, 2017 9:10 AM
Jefferies lowered its price target on Eli Lilly (NYSE: LLY) to $92.00 (from ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Analyst Comments
Analyst EPS Change
Analyst PT Change
Next Articles
Eli Lilly & Co. (LLY) Tops Q1 EPS by 2c
April 25, 2017 6:27 AM
Lilly Reports First-Quarter 2017 Results
April 25, 2017 6:25 AM
Eli Lilly & Co. (LLY) Announces Phase 3 MONARCH 3 Breast Cancer Study of Abemaciclib Meets Primary Endpoint
April 24, 2017 6:46 AM
Lilly Announces Phase 3 MONARCH 3 Breast Cancer Study of Abemaciclib Demonstrated Superior Progression-Free Survival at Interim Analysis
April 24, 2017 6:45 AM